Novabiotics - a leading clinical-stage biotechnology company
Novabiotics about us Novabiotics our news Novabiotics contact

The Institute of Podiatrists are delighted to announce their endorsement of Tinexyl PRO.

Our Medicines and Procedures Panel (MaPP) were invited to assist with the product review of Tinexyl PRO over a year ago. During this time MaPP have played an active role in product feedback/development as well as conducting a product trial which will be published in the Spring Issue of the Podiatry Review. On successful completion of our rigorous assessment criteria and as a result of the positive trial, we are delighted to announce that Tinexyl PRO has met and upholds all aspects of our criteria relating to quality, compliance, evidence of research and technical materials as well as patient and clinician satisfaction.

Gaynor Wooldridge, Chair Executive Committee: “It has been a pleasure to work with the team at Tinexyl PRO and to lead the trial of this innovative product that offers an exciting, novel approach to pathological nails. With Tinexyl PRO we have a formula pathway to offer treatments to patients presenting with damaged, onychauxic nails; I believe this revolutionises clinical practice within the foot health profession.”

Product info

Tinexyl PRO uses an advanced conditioning TXYL Polymer Technology, which promotes rejuvenation and restoration for healthier looking, and feeling, nails; it provides conditioning and rehydration to improve nail appearance and texture. The product is formulated without alcohols and organic solvents and is odour, chemical preservative, urea and paraben free.

Tinexyl PRO is gentle, yet powerfully effective, working in complete harmony with the nail tissue.

Dr Deborah A O’Neil, Tinexyl PRO:   “We are thrilled that the Institute of Podiatrists have endorsed Tinexyl PRO. The Institute’s guidance and advice in the trialling, final development and launch-readiness of this breakthrough nail health product has been invaluable. Gaynor in particular has been a critical and trusted source of clinical knowledge and support in Tinexyl PROs journey from the laboratory to patients. We look forward to continuing to work with the Institute and its members.”

Link to Institute of Podiatrists Press Release